How many studies have been conducted on Tumor Necrosis Factor Ligand Superfamily Member 14?

BiohacksAI has indexed 32 PubMed studies on Tumor Necrosis Factor Ligand Superfamily Member 14, including 1 randomized controlled trials (RCTs). 41% of studies involve human subjects.

What are the main research areas for Tumor Necrosis Factor Ligand Superfamily Member 14?

The primary research domains for Tumor Necrosis Factor Ligand Superfamily Member 14 are 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology. This is based on analysis of 32 PubMed studies using the BiohacksAI evidence platform.

Tumor Necrosis Factor Ligand Superfamily Member 14

A member of tumor necrosis factor superfamily found on activated LYMPHOCYTES and MONOCYTES. It occurs as transmembrane protein that can be cleaved to release a secreted form that specifically binds to LYMPHOTOXIN BETA RECEPTOR and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14.

32+ PubMed studies analyzed · 1 RCTs · Evidence Score: 44.6

Research Domains

Tumor Necrosis Factor Ligand Superfamily Member 14 has been studied across 11 research domains including 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology, 🔥 Metabolic, ❤️ Cardiovascular. The primary research focus is 🔬 Inflammation with 38% of studies addressing this area.

Loading evidence profile...

This evidence profile for Tumor Necrosis Factor Ligand Superfamily Member 14 is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.